Marvell Technology (MRVL) shares were on a tear Wednesday, climbing more than 6% as a parade of Wall Street analysts raised their price targets on the chipmaker. The reason? AI, AI, and more AI.
The stock hit $186.92, inching closer to its 52-week high of $192.15, and rode a broader wave of strength in AI and semiconductor stocks. But the real story is the flurry of analyst upgrades and target bumps that came out this week, each one highlighting a different piece of Marvell's AI puzzle.
Oppenheimer Sees Upside From AI Networking, Custom Chips
Oppenheimer raised its price target on Marvell to $200 from $170, keeping an Outperform rating. The firm expects strong earnings driven by AI networking demand and growth in custom ASICs as hyperscalers keep building out data centers. Oppenheimer noted that Marvell's optics business has been compounding at roughly 50% annually over the past five years and could grow more than 60% this year. The firm also called out Amazon's (AMZN) AWS Trainium and Microsoft's (MSFT) Maia as major growth drivers for Marvell's custom chip business.
RBC Capital Highlights Optical Business Strength
RBC Capital also lifted its target to $200 from $170, maintaining an Outperform rating. RBC pointed to continued strength in Marvell's optical networking business as AI data center demand expands. The firm expects Marvell to deliver a modest earnings beat, supported by sustained AI infrastructure spending.
Wells Fargo Bets on AWS Trainium Expansion
Wells Fargo made a big leap, raising its target to $195 from $135 and keeping an Overweight rating. The bank said expanding AWS Trainium deployments could significantly accelerate Marvell's Custom XPU revenue growth over the next several years. Wells Fargo also sees additional upside from Microsoft Maia and AI-related commitments tied to OpenAI and Anthropic.
Evercore ISI Points to AI Networking Demand
Evercore ISI raised its target to $155 from $133, reiterating an Outperform rating. The firm's channel checks showed strong AI networking demand and ongoing supply constraints across the semiconductor ecosystem. Evercore also noted that hyperscalers are increasingly focusing on internally developed ASICs and alternative AI accelerators as inference workloads grow.
Melius Research Raises Long-Term Outlook
Melius Research analyst Ben Reitzes went the highest, raising his target to $220 from $140 while maintaining a Buy rating. Reitzes said AI semiconductor and memory companies continue benefiting from rising infrastructure spending and long-term demand bottlenecks. He also argued that semiconductor companies could capture more long-term market value growth than traditional software firms.
CLSA Upgrades Marvell on AI Compute Demand
CLSA upgraded Marvell from Hold to Outperform as part of a broader bullish call on semiconductor stocks. The brokerage said worsening AI compute shortages and rising chip-leasing prices continue to support long-term semiconductor demand. CLSA also highlighted the growing adoption of Amazon's Trainium and Alphabet's (GOOGL) Google TPU infrastructure across Anthropic's AI ecosystem, which could benefit suppliers tied to custom AI hardware and networking.
Marvell Earnings & Analyst Outlook
The countdown is on: Marvell is set to report earnings on May 27, 2026. Here's what analysts are expecting:
- EPS Estimate: 75 cents (up from 62 cents a year ago)
- Revenue Estimate: $2.40 billion (up from $1.90 billion a year ago)
- Valuation: P/E of 57.4x — a premium relative to peers
Top ETF Exposure
Marvell's weight in key semiconductor ETFs means any significant inflows or outflows can trigger automatic buying or selling of the stock. Here are the top ETFs with exposure:
- iShares Semiconductor ETF (SOXX): 6.15% weight
- iShares Future AI & Tech ETF (ARTY): 5.10% weight
- First Trust Nasdaq Semiconductor ETF (FTXL): 5.31% weight
Significance: Because MRVL carries such a heavy weight in these funds, any significant inflows or outflows will likely trigger automatic buying or selling of the stock.
Marvell Price Action
MRVL Price Action: Marvell Technology shares were up 6.04% at $186.92 at the time of publication on Wednesday. The stock is trading near its 52-week high of $192.15.